Amortization of Intangible Assets of LISATA THERAPEUTICS, INC. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
LISATA THERAPEUTICS, INC. quarterly and annual Amortization of Intangible Assets in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • LISATA THERAPEUTICS, INC. Amortization of Intangible Assets for the quarter ending 30 Sep 2025 was $18,000, unchanged year-over-year.
  • LISATA THERAPEUTICS, INC. Amortization of Intangible Assets for the twelve months ending 30 Sep 2025 was $71,000, a 1.4% increase year-over-year.
  • LISATA THERAPEUTICS, INC. annual Amortization of Intangible Assets for 2024 was $71,000, unchanged from 2023.
  • LISATA THERAPEUTICS, INC. annual Amortization of Intangible Assets for 2023 was $71,000, a 238% increase from 2022.
  • LISATA THERAPEUTICS, INC. annual Amortization of Intangible Assets for 2022 was $21,000.
Source SEC data
View on sec.gov
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Change (%)

LISATA THERAPEUTICS, INC. Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $71,000 $18,000 $0 0% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $71,000 $18,000 $0 0% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $71,000 $17,000 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $71,000 $18,000 +$1,000 +5.9% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $70,000 $18,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $70,000 $18,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $70,000 $17,000 -$1,000 -5.6% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $71,000 $17,000 -$1,000 -5.6% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $72,000 $18,000 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $18,000 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $18,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $18,000 01 Oct 2022 31 Dec 2022 10-K 30 Mar 2023 2022 FY
Q1 2017 $142,500 $0 0% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q2 2016 $587,600 $142,500 -$8,800 -5.8% 01 Apr 2016 30 Jun 2016 10-Q 07 Nov 2016 2016 Q3
Q1 2016 $596,400 $142,500 -$8,800 -5.8% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $605,200 $151,300 $0 0% 01 Oct 2015 31 Dec 2015 10-K 17 Mar 2017 2016 FY
Q3 2015 $605,200 $151,300 $0 0% 01 Jul 2015 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $605,200 $151,300 $0 0% 01 Apr 2015 30 Jun 2015 10-Q 07 Nov 2016 2016 Q3
Q1 2015 $605,200 $151,300 $0 0% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q4 2014 $605,200 $151,300 $0 0% 01 Oct 2014 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 $605,200 $151,300 $0 0% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2015 Q3
Q2 2014 $605,200 $151,300 $0 0% 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q1 2014 $605,200 $151,300 $0 0% 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015 2015 Q1
Q4 2013 $605,200 $151,300 $0 0% 01 Oct 2013 31 Dec 2013 10-K 15 Mar 2016 2015 FY
Q3 2013 $605,200 $151,300 $0 0% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $605,200 $151,300 $0 0% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 $605,200 $151,300 $0 0% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q4 2012 $605,200 $151,300 01 Oct 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
Q3 2012 $151,300 -$60,000 -28% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013 2013 Q3
Q2 2012 $151,300 +$142,500 +1619% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013 2013 Q2
Q1 2012 $151,300 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q3 2011 $211,300 01 Jul 2011 30 Sep 2011 10-Q 13 Nov 2012 2012 Q3
Q2 2011 $8,800 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012 2012 Q2

LISATA THERAPEUTICS, INC. Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $71,000 $0 0% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $71,000 +$50,000 +238% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $21,000 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023 2022 FY
2016 $570,000 -$35,200 -5.8% 01 Jan 2016 31 Dec 2016 10-K 17 Mar 2017 2016 FY
2015 $605,200 $0 0% 01 Jan 2015 31 Dec 2015 10-K 17 Mar 2017 2016 FY
2014 $605,200 $0 0% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2016 2015 FY
2013 $605,200 $0 0% 01 Jan 2013 31 Dec 2013 10-K 15 Mar 2016 2015 FY
2012 $605,200 +$27,900 +4.8% 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
2011 $577,300 +$542,100 +1540% 01 Jan 2011 31 Dec 2011 10-K 11 Mar 2013 2012 FY
2010 $35,200 01 Jan 2010 31 Dec 2010 8-K 15 Aug 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.